impf-info.de
Nachdem Covid19 aus medizinischer Sicht "durch" ist, hier jetzt also wieder das Thema Impfen in ganzer Breite...
FDA zu Novavax: Wirksamkeit gegen Omikron "more likely than not" - 4 Fälle von Myokarditis in US-amerikanischer Zulassungsstudie...
U.S. FDA staff says Novavax vaccine lowers COVID risk | Reuters
U.S. Food and Drug Administration staff said on Friday Novavax Inc's vaccine reduces the risk of mild-to-severe COVID-19 and that it was likely the shot could provide some level of protection against the Omicron variant.
By accepting you will be accessing a service provided by a third-party external to https://impf-info.de/